• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中的核DNA含量,特别涉及恶性潜能参数。

Nuclear DNA content in breast carcinoma with special reference to the parameters of malignant potentiality.

作者信息

Suehiro S, Hamada Y, Toi M, Nakamura T, Niimoto M, Hattori T

机构信息

Department of Surgery, Hiroshima University, Japan.

出版信息

Jpn J Surg. 1990 Jan;20(1):115-8. doi: 10.1007/BF02470724.

DOI:10.1007/BF02470724
PMID:2304282
Abstract

Nuclear DNA ploidy pattern was examined in 22 breast carcinomas with a tumor mass of up to 2.2 cm and compared with the clinical and histological parameters of the malignant potentiality of breast carcinomas. The 22 carcinomas were divided into 11 aneuploid and 11 near-diploid carcinomas. It was found that the histological type, histological grade, nuclear grade, mitotic index and lymphatic invasion were either only slightly, or not correlated at all with the DNA ploidy pattern. Nevertheless, lymph node metastasis and negative estrogen receptor status was more frequently seen in the patients with aneuploid carcinoma than in those with near-diploid carcinoma.

摘要

对22例肿瘤肿块最大达2.2 cm的乳腺癌进行了核DNA倍体模式检测,并与乳腺癌恶性潜能的临床和组织学参数进行了比较。这22例癌被分为11例非整倍体癌和11例近二倍体癌。结果发现,组织学类型、组织学分级、核分级、有丝分裂指数和淋巴浸润与DNA倍体模式要么仅有轻微关联,要么完全无关联。然而,非整倍体癌患者比近二倍体癌患者更常出现淋巴结转移和雌激素受体阴性状态。

相似文献

1
Nuclear DNA content in breast carcinoma with special reference to the parameters of malignant potentiality.乳腺癌中的核DNA含量,特别涉及恶性潜能参数。
Jpn J Surg. 1990 Jan;20(1):115-8. doi: 10.1007/BF02470724.
2
The relationship of estrogen receptor status to DNA ploidy in breast cancer.雌激素受体状态与乳腺癌中DNA倍体的关系。
Surg Today. 1992;22(2):105-9. doi: 10.1007/BF00311332.
3
Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.人类乳腺癌的核DNA含量与预后:一项静态细胞光度学研究。
Breast Cancer Res Treat. 1987;9(2):101-9. doi: 10.1007/BF01807362.
4
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.乳腺癌中DNA倍体和细胞增殖的短期意义:对308例患者预后标志物的多变量分析
J Clin Pathol. 1999 Aug;52(8):604-11. doi: 10.1136/jcp.52.8.604.
5
Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor.乳腺癌的流式细胞术:I. DNA倍体水平与组织学及雌激素受体的关系
Cancer. 1981 Aug 15;48(4):980-4. doi: 10.1002/1097-0142(19810815)48:4<980::aid-cncr2820480421>3.0.co;2-7.
6
Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?DNA倍体是否为浸润性淋巴结阴性乳腺腺癌的独立预后指标?
Cancer. 1990 Apr 1;65(7):1577-82. doi: 10.1002/1097-0142(19900401)65:7<1577::aid-cncr2820650721>3.0.co;2-d.
7
Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content.人乳腺癌的倍体水平。与组织病理学特征和激素受体含量的关系。
Acta Radiol Oncol. 1984;23(2-3):103-7. doi: 10.3109/02841868409135997.
8
Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.
Am J Clin Oncol. 1996 Feb;19(1):54-8. doi: 10.1097/00000421-199602000-00012.
9
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.
10
[Relation of steroid receptors, tumor ploidy, and cell proliferation in various histologic types of breast cancer].[不同组织学类型乳腺癌中类固醇受体、肿瘤倍体与细胞增殖的关系]
Arkh Patol. 1989;51(3):10-6.

本文引用的文献

1
The influence of pathologic factors on breast cancer management.病理因素对乳腺癌治疗的影响。
Cancer. 1980 Aug 15;46(4 Suppl):961-76. doi: 10.1002/1097-0142(19800815)46:4+<961::aid-cncr2820461319>3.0.co;2-u.
2
Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor.乳腺癌的流式细胞术:II. 肿瘤细胞周期分布与组织学及雌激素受体的关系
Cancer. 1981 Aug 15;48(4):985-8. doi: 10.1002/1097-0142(19810815)48:4<985::aid-cncr2820480422>3.0.co;2-q.
3
Nuclear feulgen DNA content and nuclear size in human breast carcinoma.
人类乳腺癌中的核福尔根DNA含量与核大小
Hum Pathol. 1982 Jul;13(7):626-30. doi: 10.1016/s0046-8177(82)80004-x.
4
Estrogen receptor content and ploidy of human mammary carcinoma.人类乳腺癌的雌激素受体含量与倍性
Cancer. 1982 Nov 1;50(9):1771-4. doi: 10.1002/1097-0142(19821101)50:9<1771::aid-cncr2820500921>3.0.co;2-7.
5
Modal deoxyribonucleic acid value and survival in carcinoma of the breast.乳腺癌的模态脱氧核糖核酸值与生存率
Br Med J. 1972 Jan 29;1(5795):271-2. doi: 10.1136/bmj.1.5795.271.
6
Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics.
Cancer. 1986 Feb 15;57(4):808-11. doi: 10.1002/1097-0142(19860215)57:4<808::aid-cncr2820570421>3.0.co;2-#.
7
[Experimental and clinical study on flow cytometric DNA analysis of human breast carcinoma].[人乳腺癌流式细胞术DNA分析的实验与临床研究]
Nihon Geka Gakkai Zasshi. 1988 May;89(5):737-46.
8
DNA in human tumors: a cytophotometric study.人类肿瘤中的DNA:一项细胞光度学研究。
Curr Top Pathol. 1975;60:151-219. doi: 10.1007/978-3-642-66215-7_5.
9
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.雌激素受体作为乳腺癌早期复发的独立预后因素。
Cancer Res. 1977 Dec;37(12):4669-71.
10
The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).浸润性乳腺癌的病理学。一份源自国家乳腺癌手术辅助项目(协议编号4)研究结果的教学大纲。
Cancer. 1975 Jul;36(1):1-85. doi: 10.1002/1097-0142(197507)36:1<1::aid-cncr2820360102>3.0.co;2-4.